MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • 2016 International Congress

    The scale for assessment and rating of ataxia in early onset ataxia; always a reliable biomarker?

    R. Brandsma, T.F. Lawerman, M.J. Kuiper, I.J. Lunsing, H. Burger, D.A. Sival (Groningen, Netherlands)

    Objective: To determine the reliability and discriminant validity of the Scale for Assessment and Rating of Ataxia (SARA) in early onset ataxia. Background: Early onset…
  • 2016 International Congress

    The International Parkinson and Movement Disorder Society – non-motor rating scale (MDS-NMS): Results from the cognitive pre-testing and phases 1 and 2 of an international validation

    K. Ray Chaudhuri, D. Weintraub, A. Schrag, P. Martinez-Martin, On behalf of EUROPAR, The MDS Non-Motor PD Study Group (London, United Kingdom)

    Objective: To revise the Non-Motor Sumptom Scale (NMSS) and develop a new up to date version, the MDS-NMS, a project commissioned by the International Parkinson…
  • 2016 International Congress

    Application and correlates of the PSP quality of life scale

    L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

    Objective: To apply the PSP Quality of Life scale (PSP-QoL) within a cross-sectional PSP population and correlate these scores with those of the PSP rating…
  • 2016 International Congress

    Long-term impact of lead poisoning on neurologic function in children and adolescents

    N.T. Boyd, M.J. Kuiper, R. Brandsma, T.F. Lawerman, R.J. Lunsing, F. Serrano, C. Olivera, D.A. Sival (Groningen, Netherlands)

    Objective: To elucidate (1) whether prolonged effects of lead exposure are persistently reflected by impaired neurological parameters and (2) whether these outcomes can be attributed…
  • 2016 International Congress

    Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)

    H. Yasar, M.G. Senol, S. Tasdemir, U.H. Ulas, S. Alay (Ankara, Turkey)

    Objective: The aim of this study was to evaluate the validity and reliability of the Turkish version of the SCOPA-AUT. Background: The scales for outcomes…
  • 2016 International Congress

    Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism

    Y. Kim, J.M. Seok, H.J. Kim, J. Youn, B.J. Kim, J.W. Cho (Seoul, Korea)

    Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…
  • 2016 International Congress

    The practicalities of freezing of gait assessment methods

    C. Stummer, E. Mallia, B. Debû, B.R. Bloem, M.U. Ferraye (Nijmegen, Netherlands)

    Objective: To highlight the available assessment tools and to provide practical, experience-based recommendations for reliable assessment of freezing of gait (FOG). Background: FOG is a…
  • 2016 International Congress

    Comparison of change in the UPDRS verses MDS-UPDRS in a population of Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS)

    S.S. Wang, N.B. Galifianakis, M. San Luciano, P.S. Larson, P.A. Starr, N. Ziman, J.L. Ostrem (San Francisco, CA, USA)

    Objective: To compare assessment tools for capturing the therapeutic effect of DBS for treating PD using the original UPDRS and The Movement Disorder Society-sponsored revision…
  • 2016 International Congress

    Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2

    K. Suzuki, A. Numao, T. Kadowaki, S. Suzuki, Y. Watanabe, M. Miyamoto, T. Miyamoto, T. Uchiyama, K. Hashimoto, H. Fujita, Y. Watanabe, T. Matsubara, K. Hirata (Mibu, Japan)

    Objective: To evaluate the relationship between fatigue and sleep disturbances in patients with Parkinson's disease (PD). Background: In patients with PD, fatigue is an important…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley